Eyenovia, Inc.
NASDAQ: EYEN0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Michael M. Rowe
- Employees
- 13
- Headquarters
- New York City, United States
- IPO year
- 2018
- Market cap
- $38.6M
- Website
- https://www.eyenovia.com
Loading EYEN…
Loading profile data…Frequently asked questions about EYEN
What does Eyenovia, Inc. (EYEN) do?
Eyenovia, Inc., a New York-based company established in 2014 (originally incorporated as PGP Holdings V, Inc.), functions as a clinical-stage pharmaceutical firm specializing in ophthalmology. The company utilizes its exclusive microdose array print platform technology and the Optejet branded targeted ocular delivery system to formulate innovati...
Where does EYEN trade?
Eyenovia, Inc. (EYEN) trades on the NASDAQ Capital Market.
What sector is EYEN in?
Eyenovia, Inc. (EYEN) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Eyenovia, Inc.?
Michael M. Rowe is the chief executive officer of Eyenovia, Inc. (EYEN).
Where is Eyenovia, Inc. headquartered?
Eyenovia, Inc. is headquartered in United States.
Does EYEN pay a dividend?
Eyenovia, Inc. (EYEN) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did EYEN go public?
Eyenovia, Inc. (EYEN) completed its initial public offering in 2018.